Ebp50, A β–Catenin-Associating Protein, Enhances Wnt Signaling and Is Over–Expressed in Hepatocellular Carcinoma
The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
Wnt signaling mediated by β–catenin plays crucial roles in the development of hepatocellular carcinoma and other cancers such as colorectal cancer. β–Catenin associates with T–cell factor (TCF) transcription factors and functions as a transcriptional activator in the nucleus. By protein interaction screening, we identified EBP50, a cytoplasmic protein with 2 PDZ domains, as a β–catenin–associating molecule. EBP50 interacted with β–catenin through its carboxyl–PDZ domain in vitro and in vivo. Northern blot and RT–PCR analysis revealed an increase of EBP50 messenger RNA (mRNA) in hepatocellular carcinoma (HCC) cell lines and surgical specimens of human HCC. Over–expression of EBP50 protein with focal nuclear localization was detected in human HCC. In human HCC and colorectal cancer cell lines, EBP50 enhanced β–catenin/TCF–dependent transcription in a dose–dependent manner. In an HCC cell line, over–expression of the carboxyl PDZ domain resulted in a decrease of endogenous β–catenin/TCF transactivation. EBP50 promoted β–catenin–mediated transactivation only in cells in which β–catenin was already stabilized, suggesting that EBP50 may work with stabilized β–catenin for transcriptional regulation. In conclusion, the EBP50/β–catenin complex promotes Wnt signaling, and over–expression of EBP50 may work cooperatively with β–catenin in the development of liver cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Polakis, P. (2000) · Genes & Development · doi:10.1101/gad.14.15.1837 · Cited by 3,183
Recognition of Unique Carboxyl-Terminal Motifs by Distinct PDZ Domains
Songyang, Z., Fanning, A. S., Fu, C., Xu, J., Marfatia, S. M., Chishti, A. H., Crompton, A., Chan, A. C., Anderson, J. M., & Cantley, L. C. (1997) · Science · doi:10.1126/science.275.5296.73 · Cited by 1,385
Cited by
Stem cell origin of cancer and differentiation therapy
Sell, S. (2004) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2004.04.007 · Cited by 638
PTEN Tumor Suppressor Network in PI3K-Akt Pathway Control
Georgescu, M.-M. (2010) · Genes & Cancer · doi:10.1177/1947601911407325 · Cited by 482
Dysregulation of growth factor signaling in human hepatocellular carcinoma
Breuhahn, K., Longerich, T., & Schirmacher, P. (2006) · Oncogene · doi:10.1038/sj.onc.1209556 · Cited by 391
Blazer, L. L., & Neubig, R. R. (2009) · Neuropsychopharmacology · doi:10.1038/npp.2008.151 · Cited by 197
“For example, the Na + /H + exchanger regulatory factor 1 (NHERF1) contains two PDZ domains and has been shown to have altered expression in many cancers (Cardone et al, 2007; Kreimann et al, 2007; Pan et al, 2006; Shibata et al, 2003; Voltz et al, 2001).”
BackgroundBush, M., Alhanshali, B. M., Qian, S., Stanley, C. B., Heller, W. T., Matsui, T., Weiss, T. M., Nicholl, I. D., Walz, T., Callaway, D. J. E., et al. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1911489116 · Cited by 42
Metadata
- Authors
- Shibata, T., Chuma, M., Kokubu, A., Sakamoto, M., & Hirohashi, S.
- Venue
- Hepatology
- Published
- 2003-07
- Volume
- 38
- Issue
- 1
- Pages
- 178-186
- ISSN
- 0270-9139 (ISSN-L)
- OpenAlex
- W1999384023
- Cited by
- 155
- References
- 2
- FWCI
- 1.72
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Ebp50, A β–Catenin-Associating Protein, Enhances Wnt Signaling and Is Over–Expressed in Hepatocellular Carcinoma. https://app.cochat.ai/papers/10.1053/jhep.2003.50270
- The paper
- Shibata, T., Chuma, M., Kokubu, A., Sakamoto, M., & Hirohashi, S. (2003). Ebp50, A β–Catenin-Associating Protein, Enhances Wnt Signaling and Is Over–Expressed in Hepatocellular Carcinoma. Hepatology. https://doi.org/10.1053/jhep.2003.50270
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.